Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Walmsley

Showing results (131-140 of 199) with videos related to

Pageof 20
Sort By:
Trials|March 23, 2021
Post-exposure prophylaxis against SARS-CoV-2 in close contacts of confirmed COVID-19 cases (CORIPREV): study protocol for a cluster-randomized trialDarrell H S Tan, Adrienne K Chan, Peter Jüni, et al.
Cancers|January 10, 2026
Human Papillomavirus Self-Sampling Attitudes Amongst Women Living with HIV Prior to a Self-Sampling InterventionSofia Nicolls, Emma Karlsen, Isabelle Boucoiran, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 10, 2018
The Efficacy of the Quadrivalent Human Papillomavirus Vaccine in Girls and Women Living With Human Immunodeficiency VirusElisabeth McClymont, Marette Lee, Janet Raboud, et al.
The Journal of Antimicrobial Chemotherapy|February 17, 2025
Early clinical experience using tecovirimat during the 2022 mpox epidemic in Toronto underscores ongoing clinical equipoise and the need for randomized trialsShreya S Khera, Sharmistha Mishra, Oscar Javier Pico Espinosa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 26, 2002
A safety study of oral valganciclovir maintenance treatment of cytomegalovirus retinitisJacob Lalezari, Janette Lindley, Sharon Walmsley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 29, 2011
Comparison of abacavir/lamivudine and tenofovir/emtricitabine among treatment-naive HIV-infected patients initiating therapyDarrell H S Tan, Keith Chan, Janet Raboud, et al.
Antiviral Therapy|October 13, 2005
A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients: the MaxCmin2 trialUlrik B Dragsted, Jan Gerstoft, Mike Youle, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|April 29, 2020
Prevalent and persistent oncogenic HPV types in a cohort of women living with HIV prior to HPV vaccinationElisabeth McClymont, Marette Lee, Janet Raboud, et al.
BMC Medical Research Methodology|August 12, 2022
Predicting the presence of depressive symptoms in the HIV-HCV co-infected population in Canada using supervised machine learningGayatri Marathe, Erica E M Moodie, Marie-Josée Brouillette, et al.
The Journal of Infectious Diseases|September 9, 2025
Monkeypox virus shedding despite tecovirimat treatment in a cohort in Toronto, CanadaJacklyn R Hurst, Mary Addo, Abby Li, et al.
Pageof 20

Showing results (131-140 of 199) with videos related to

Sort By:
Pageof 20
Trials|March 23, 2021
Post-exposure prophylaxis against SARS-CoV-2 in close contacts of confirmed COVID-19 cases (CORIPREV): study protocol for a cluster-randomized trialDarrell H S Tan, Adrienne K Chan, Peter Jüni, et al.
Cancers|January 10, 2026
Human Papillomavirus Self-Sampling Attitudes Amongst Women Living with HIV Prior to a Self-Sampling InterventionSofia Nicolls, Emma Karlsen, Isabelle Boucoiran, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 10, 2018
The Efficacy of the Quadrivalent Human Papillomavirus Vaccine in Girls and Women Living With Human Immunodeficiency VirusElisabeth McClymont, Marette Lee, Janet Raboud, et al.
The Journal of Antimicrobial Chemotherapy|February 17, 2025
Early clinical experience using tecovirimat during the 2022 mpox epidemic in Toronto underscores ongoing clinical equipoise and the need for randomized trialsShreya S Khera, Sharmistha Mishra, Oscar Javier Pico Espinosa, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 26, 2002
A safety study of oral valganciclovir maintenance treatment of cytomegalovirus retinitisJacob Lalezari, Janette Lindley, Sharon Walmsley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 29, 2011
Comparison of abacavir/lamivudine and tenofovir/emtricitabine among treatment-naive HIV-infected patients initiating therapyDarrell H S Tan, Keith Chan, Janet Raboud, et al.
Antiviral Therapy|October 13, 2005
A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients: the MaxCmin2 trialUlrik B Dragsted, Jan Gerstoft, Mike Youle, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|April 29, 2020
Prevalent and persistent oncogenic HPV types in a cohort of women living with HIV prior to HPV vaccinationElisabeth McClymont, Marette Lee, Janet Raboud, et al.
BMC Medical Research Methodology|August 12, 2022
Predicting the presence of depressive symptoms in the HIV-HCV co-infected population in Canada using supervised machine learningGayatri Marathe, Erica E M Moodie, Marie-Josée Brouillette, et al.
The Journal of Infectious Diseases|September 9, 2025
Monkeypox virus shedding despite tecovirimat treatment in a cohort in Toronto, CanadaJacklyn R Hurst, Mary Addo, Abby Li, et al.
Pageof 20